{
  "docId": "019de075-7539-774f-abd7-26734f481c17",
  "docSlug": "efb32a48c20b71d9dd70ea37e2f1bc4b",
  "documentTitle": "argenx SE | Investor Presentation Deck | 26 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 26,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "other",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide outlines a clinical trial protocol using a timeline-based process flow.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de075-7539-774f-abd7-26734f481c17/22",
  "deckHref": "/decks/019de075-7539-774f-abd7-26734f481c17",
  "deckJsonHref": "/decks/019de075-7539-774f-abd7-26734f481c17.json",
  "deckAnchorHref": "/decks/019de075-7539-774f-abd7-26734f481c17#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.25,
        "y": 0.85
      },
      "kind": "callout",
      "text": "Topline data expected 4Q 2023",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e21e64a6-1e4c-44a9-af0d-7719e7a8176e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.75,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Screening to Randomization to 30-week treatment timeline",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "434f9c19-dae5-4837-b47f-2646b2cd3dd9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.18,
        "x": 0.8,
        "y": 0.3
      },
      "kind": "list",
      "text": "Primary endpoint is proportion of PV patients achieving CRmin* within 30 weeks. N=sample size estimation ≤150 patients (PV and PF) with PF patients capped. Followed by Open Label Extension study",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cfbd8327-986c-431d-8aa1-8b2c275baa59",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.02,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "CR=complete clinical remission; CRmin=complete remission on minimal therapy; EoC=end of consolidation; SC=subcutaneous.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4064ffda-415a-409a-b3c9-64d8b7ae1a63",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Pemphigus ADDRESS Trial: Focus on Fast Onset and Steroid-sparing",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a48f6863-827b-4162-b5a4-75b34ce99b0b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "a9fc3100-7218-48e4-b424-961241f13fba",
      "evidence": "The slide depicts a sequential clinical trial process over a 30-week period.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 22,
      "from": 17,
      "beatId": "480800cd-70e9-4515-9ba7-53fd5332fee0",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Visualization",
      "beatSlug": "monroes-sequence-visualization",
      "evidence": "Slides 17-22 present various trials and studies, visualizing the company's progress.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}